Inventor

MATTHEWS DONALD P

US40 patents

⚠️ This page may combine multiple inventors who share the name “MATTHEWS DONALD P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MATTHEWS DONALD P

MERRELL DOW PHARMA

Inhibitors of lysyl oxidase

2&#39;-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositions

Triaryl-ethylene derivatives

2,2&#39;-bi-1H-imidazoles

Thiazolyl methyl)-2-2&#39;-Bi-1H-imidazoles and use as hypertensive agents

Thione dopamine beta hydroxylase inhibitors

Hypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium salts

Novel imidazole dopamine beta hydroxylase inhibitors

Hypoglycemic N-(2-substituted-3-dialkylamino-2-propenylidene)-N-alkylalkanaminium salts

Allenyl amines

Allenyl amines

Novel thione dopamine beta hydroxylase inhibitors

Process for preparing heteroaromatic methyl)-2,2&#39;-bi-1H-imidazoles

(Aryl or heteroaromatic methyl)-2,2&#39;-bi-1H-imidazoles and their use as anti-hypertensive agents

Pharmaceutically active 3-aryl-2-fluoro-1-olefins

Hypoglycemic N-(2-substituted-3-Dialkylamino-2-propenylidene)-N-alkylalkanaminium salts

MERRELL PHARMA INC

2&#39;-halomethylidene, 2&#39;-ethenylidene and 2&#39;-ethynyl cytidine, uridine and guanosine derivatives

2-&#39;-ethenylidene cytidine, uridine and guanosine derivatives

Treatment of carcinoma by administration of 2&#39;-halomethylidenyl-2&#39;-deoxynucleosides

Triaryl-ethylene derivatives

5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Process for the preparation of ribonucleotide reductase inhibitors

Process for the preparation of ribonucleotide reductase inhibitors

2&#39;-halomethylidene, 2&#39;-ethenylidene and 2&#39;-ethynl cytidine, uridine and guanosine derivatives

DOW CHEMICAL CO

Hypoglycemic 4-(((1,3,4, thiadiazolyl)thio)methyl)benzoic acids, ester and amides

Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof

4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use

Hypolipidemic cycloalkylaminobenzoic acids

Hypolipidemic benzylaminobenzene alkanoic or alkenoic acids

Substituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemia

Hypoglycemic phenylpropynylamino benzoic acids

LILLY CO ELI

Modulators of peroxisome proliferator activated receptors

Modulators of peroxisome proliferator activated receptors

Modulators of peroxisome proliferator activated receptors

BROADCOM CORP

Methods and apparatus for performing encryption and authentication

Cryptography accelerator data routing unit

Cryptography accelerator interface decoupling from cryptography processing cores

BOEING CO

Address-dependent key generator by XOR tree

HOESCHST MARION ROUSSEL INC

Process for the preparation of ribonucleotide reductase inhibitors

MERRELL DOW PHARMACEUTICAL

Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins

2'-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositions

2,2'-bi-1H-imidazoles

Thiazolyl methyl)-2-2'-Bi-1H-imidazoles and use as hypertensive agents

Process for preparing heteroaromatic methyl)-2,2'-bi-1H-imidazoles

(Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents

2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives

2-'-ethenylidene cytidine, uridine and guanosine derivatives

Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides

2'-halomethylidene, 2'-ethenylidene and 2'-ethynl cytidine, uridine and guanosine derivatives